Has Wen Xu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,699 in general payments to Wen Xu, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wen Xu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wen Xu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wen Xu, MD

Surgery of the Hand · Columbus, OHNPI 1013443449

Payments from drug & device makers

What this record shows

This record is dominated by grants: $10,000 of the $12,699 with a category attached, or 78.7%. Arthrex accounts for 88.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $10,000 and has fallen 99.9% since, to $12 in 2025.

$12,699in general payments, 2019–2025

Across 31 payments — averaging $409.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$11K
Axogen$456
Acumed LLC$331
Davol Inc.$238
Endo Pharmaceuticals Inc.$159
Alafair Biosciences, Inc.$121
plus $124 from 2 others

What the payments were for

Grants$10,00079%
Travel & lodging$1,0388%
Food & beverage$1,66113%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	19	$11,270
Axogen	3	$456
Acumed LLC	3	$331
Davol Inc.	1	$238
Endo Pharmaceuticals Inc.	2	$159
Alafair Biosciences, Inc.	1	$121
CDC Medical LLC	1	$111
Medartis Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,699 in reported general payments places this provider in the 75th percentile of 26 surgery of the hand providers in Ohio.

See all surgery of the hand providers in Ohio →

Medicare billing

Part B allowed, 2024

$8,733

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ibuprofen	14	$83
Oxycodone Hcl	16	$52

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Columbus

Ryan SchmuckerColumbus$18K
John BaileyColumbus$18K
Arminder KauraColumbus$14K
Andrew ObrienColumbus$8K
Ronald BrownColumbus$1K
Desmond StutzmanColumbus$807
Kyle CheplaCleveland$163K
Joseph KhouriBeachwood$137K
Eric JiangLiberty Township$17K
Haiqiao JiaoAkron$11K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →